{"id":1958,"date":"2022-09-07T10:20:45","date_gmt":"2022-09-07T10:20:45","guid":{"rendered":"https:\/\/www.ekachaihospital.com\/en\/?page_id=1958"},"modified":"2026-03-10T08:57:00","modified_gmt":"2026-03-10T08:57:00","slug":"news-announcements","status":"publish","type":"page","link":"https:\/\/www.ekachaihospital.com\/en\/ir\/news-announcements\/","title":{"rendered":"News announcements"},"content":{"rendered":"\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
DATE<\/strong><\/td>\nAnnouncements<\/strong><\/td>\n<\/tr>\n
02 Mar 2026<\/td>\nRelated Party Transaction of a Subsidiary (Acquisition of Land in Replacement of Lease)<\/a><\/td>\n<\/tr>\n
27 Feb 2026<\/td>\nDividend payment and 2026 Annual General Meeting of Shareholders<\/a><\/td>\n<\/tr>\n
27 Feb 2026<\/td>\nFinancial Performance Yearly (F45) (Audited)<\/a><\/td>\n<\/tr>\n
27 Feb 2026<\/td>\nManagement Discussion and Analysis Yearly Ending 31 Dec 2025<\/a><\/td>\n<\/tr>\n
29 Jan 2026<\/td>\nReport on the utilization of proceeds from the Capital Increase from Private Placement and from the Exercising of EKH-W1<\/a><\/td>\n<\/tr>\n
13 Nov 2025<\/td>\nFinancial Performance Quarter 3 (F45) (Reviewed)<\/a><\/td>\n<\/tr>\n
13 Nov 2025<\/td>\nManagement Discussion and Analysis Quarter 3 Ending 30 Sep 2025<\/a><\/td>\n<\/tr>\n
31 Oct 2025<\/td>\nRights of shareholders to propose 2026 AGM agenda and nominate director candidates<\/a><\/td>\n<\/tr>\n
13 Aug 2025<\/td>\nFinancial Performance Quarter 2 (F45) (Reviewed)<\/a><\/td>\n<\/tr>\n
13 Aug 2025<\/td>\nManagement Discussion and Analysis Quarter 2 Ending 30 Jun 2025<\/a><\/td>\n<\/tr>\n
13 Aug 2025<\/td>\nFinancial Performance Quarter 2 (F45) (Reviewed)<\/a><\/td>\n<\/tr>\n
31 Jul 2025<\/td>\nReport on the utilization of proceeds from the Capital Increase from Private Placement and from the Exercising of EKH-W1<\/a><\/td>\n<\/tr>\n
14 Jul 2025<\/td>\nNotification on the End of the Share Repurchase Project for Financial Management Purposes<\/a><\/td>\n<\/tr>\n
11 Jul 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
11 Jul 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
08 Jul 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
07 Jul 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
04 Jul 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
03 Jul 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
02 Jul 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
01 Jul 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
30 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
30 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes (Revised)<\/a><\/td>\n<\/tr>\n
27 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
26 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
25 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
24 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
23 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
23 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
19 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
18 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
17 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
16 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
13 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
13 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
11 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
10 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
09 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
06 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
05 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
05 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
04 Jun 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
29 May 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
29 May 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
27 May 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
27 May 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
23 May 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
23 May 2025<\/td>\nNotification of Appointment of Chairman of the Audit Committee and Audit Committee Member in Replacement of Resigned Members<\/a><\/td>\n<\/tr>\n
22 May 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
21 May 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
20 May 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
19 May 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
16 May 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
15 May 2025<\/td>\nManagement Discussion and Analysis Quarter 1 Ending 31 Mar 2025 (Revised)<\/a><\/td>\n<\/tr>\n
14 May 2025<\/td>\nNotification of director resignation and appointment of new Chairman of the Board<\/a><\/td>\n<\/tr>\n
14 May 2025<\/td>\nManagement Discussion and Analysis Quarter 1 Ending 31 Mar 2025<\/a><\/td>\n<\/tr>\n
14 May 2025<\/td>\nFinancial Performance Quarter 1 (F45) (Reviewed)<\/a><\/td>\n<\/tr>\n
09 May 2025<\/td>\nNotification of the Resignation of the Directors<\/a><\/td>\n<\/tr>\n
08 May 2025<\/td>\nPublication of Minutes of 2025 Annual General Meeting of Shareholders on website<\/a><\/td>\n<\/tr>\n
30 Apr 2025<\/td>\nNotification of the resolution on the appointment of an Independent Director and Audit Committee Member to replace a retiring Director<\/a><\/td>\n<\/tr>\n
25 Apr 2025<\/td>\nShareholders meeting’s resolution<\/a><\/td>\n<\/tr>\n
11 Apr 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
10 Apr 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
09 Apr 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
08 Apr 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
08 Apr 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
03 Apr 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
02 Apr 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
01 Apr 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
01 Apr 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
28 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
27 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
26 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
26 Mar 2025<\/td>\nPublication of Invitation of Annual General Meeting of Shareholders for the Year 2025 on Company’s website<\/a><\/td>\n<\/tr>\n
26 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
25 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
25 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes (Revised)<\/a><\/td>\n<\/tr>\n
24 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
20 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
19 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
18 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
17 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
17 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
13 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
12 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
11 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
10 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
07 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
06 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
05 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
04 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
04 Mar 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
28 Feb 2025<\/td>\nDividend payment and 2025 Annual Ordinary General Meeting of Shareholders<\/a><\/td>\n<\/tr>\n
27 Feb 2025<\/td>\nManagement Discussion and Analysis Yearly Ending 31 Dec 2024<\/a><\/td>\n<\/tr>\n
27 Feb 2025<\/td>\nFinancial Performance Yearly (F45) (Audited) (Revised)<\/a><\/td>\n<\/tr>\n
27 Feb 2025<\/td>\nFinancial Performance Yearly (F45) (Audited)<\/a><\/td>\n<\/tr>\n
10 Feb 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
07 Feb 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
07 Feb 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
05 Feb 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
04 Feb 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
03 Feb 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
03 Feb 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
30 Jan 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
30 Jan 2025<\/td>\nReport on the utilization of proceeds from the Capital Increase from Private Placement and from the Exercising of EKH-W1<\/a><\/td>\n<\/tr>\n
30 Jan 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
29 Jan 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
28 Jan 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
24 Jan 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
24 Jan 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
23 Jan 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
21 Jan 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
20 Jan 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
17 Jan 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
16 Jan 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
15 Jan 2025<\/td>\nReporting Share Repurchase form for financial management purposes<\/a><\/td>\n<\/tr>\n
10 Jan 2025<\/td>\nResolution of the Board of Directors’ Meeting on the Share Repurchase Program for Financial Management (Revised)<\/a><\/td>\n<\/tr>\n
09 Jan 2025<\/td>\nResolution of the Board of Directors’ Meeting on the Share Repurchase Program for Financial Management<\/a><\/td>\n<\/tr>\n
03 Dec 2024<\/td>\nNew shares of EKH to be traded on December 4, 2024<\/a><\/td>\n<\/tr>\n
25 Nov 2024<\/td>\nReport on the results of the Exercise of EKH-W1 (F53-5)<\/a><\/td>\n<\/tr>\n
13 Nov 2024<\/td>\nFinancial Performance Quarter 3 (F45) (Reviewed)<\/a><\/td>\n<\/tr>\n
13 Nov 2024<\/td>\nManagement Discussion and Analysis Quarter 3 Ending 30 Sep 2024<\/a><\/td>\n<\/tr>\n
16 Oct 2024<\/td>\n18 October 2024 is the last trading day of EKH-W1<\/a><\/td>\n<\/tr>\n
02 Oct 2024<\/td>\nRights of shareholders to propose 2025 AGM agenda and nominate director candidates<\/a><\/td>\n<\/tr>\n
19 Sep 2024<\/td>\nTrading Suspension and termination of listing status of EKH-W1<\/a><\/td>\n<\/tr>\n
17 Sep 2024<\/td>\nNotification the final exercise and request for suspension of EKH-W1<\/a><\/td>\n<\/tr>\n
19 Aug 2024<\/td>\nClarifying the non-adjustment of warrant rights No. 1 (EKH-W1)<\/a><\/td>\n<\/tr>\n
15 Aug 2024<\/td>\nNo Right Adjustment of EKH-W1<\/a><\/td>\n<\/tr>\n
15 Aug 2024<\/td>\nProviding financial assistance to subsidiaries<\/a><\/td>\n<\/tr>\n
15 Aug 2024<\/td>\nEstablishment of a subsidiary company<\/a><\/td>\n<\/tr>\n
14 Aug 2024<\/td>\nInterim dividend payment<\/a><\/td>\n<\/tr>\n
14 Aug 2024<\/td>\nManagement Discussion and Analysis Quarter 2 Ending 30 Jun 2024<\/a><\/td>\n<\/tr>\n
14 Aug 2024<\/td>\nFinancial Performance Quarter 2 (F45) (Reviewed)<\/a><\/td>\n<\/tr>\n
30 Jul 2024<\/td>\nReport on the utilization of proceeds from the Capital Increase from Private Placement and the Exercising of EKH-W1<\/a><\/td>\n<\/tr>\n
07 Jun 2024<\/td>\nNew shares of EKH to be traded on June 10, 2024<\/a><\/td>\n<\/tr>\n
04 Jun 2024<\/td>\nReport on the results of the Exercise of EKH-W1 (F53-5)<\/a><\/td>\n<\/tr>\n
30 May 2024<\/td>\nThe information of the disposition of Investment in The Klinique Medical Clinic Public Company Limited (Update)<\/a><\/td>\n<\/tr>\n
24 May 2024<\/td>\nThe information of the disposition of Investment in The Klinique Medical Clinic Public Company Limited<\/a><\/td>\n<\/tr>\n
24 May 2024<\/td>\nNew shares of EKH to be traded on May 27, 2024<\/a><\/td>\n<\/tr>\n
20 May 2024<\/td>\nReport on the result of stock dividend allocation (F53-5)<\/a><\/td>\n<\/tr>\n
13 May 2024<\/td>\nSubmission of the Minutes of the 2024 Annual General Meeting of Shareholders to the Stock Exchange of Thailand and Publication on the Company’s Website<\/a><\/td>\n<\/tr>\n
13 May 2024<\/td>\nManagement Discussion and Analysis Quarter 1 Ending 31 Mar 2024<\/a><\/td>\n<\/tr>\n
10 May 2024<\/td>\nFinancial Performance Quarter 1 (F45) (Reviewed)<\/a><\/td>\n<\/tr>\n
07 May 2024<\/td>\nNotification the exercise of EKH-W1<\/a><\/td>\n<\/tr>\n
02 May 2024<\/td>\nForm to Report on Names of Members and Scope of Work of the Audit Committee (F24-1)<\/a><\/td>\n<\/tr>\n
26 Apr 2024<\/td>\nShareholders meeting’s resolution<\/a><\/td>\n<\/tr>\n
27 Mar 2024<\/td>\nPublication of Invitation of Annual General Meeting of Shareholders for the Year 2024 on Company’s Website<\/a><\/td>\n<\/tr>\n
13 Mar 2024<\/td>\nClarification of trading of Big Lot shares<\/a><\/td>\n<\/tr>\n
01 Mar 2024<\/td>\nRight Adjustment of EKH-W1<\/a><\/td>\n<\/tr>\n
01 Mar 2024<\/td>\nDividend payment, Right adjustment for warrants exercise and 2024 Annual Ordinary General Meeting of Shareholders (Revised)<\/a><\/td>\n<\/tr>\n
01 Mar 2024<\/td>\n\n
\n
\n
\n
\n
Dividend payment, Right adjustment for warrants exercise and 2024 Annual Ordinary General Meeting of Shareholders<\/span><\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/td>\n<\/tr>\n
29 Feb 2024<\/td>\n\n
\n
\n
\n
\n
Management Discussion and Analysis Yearly Ending 31 Dec 2023<\/span><\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/td>\n<\/tr>\n
29 Feb 2024<\/td>\nFinancial Performance Yearly (F45) (Audited)<\/a><\/td>\n<\/tr>\n
30 Jan 2024<\/td>\nReport on the utilization of proceeds from the Capital Increase from Private Placement and from the Exercising of EKH-W1<\/a><\/td>\n<\/tr>\n
12 Dec 2023<\/td>\n\n
\n

New shares of EKH to be traded on December 13, 2023<\/a><\/p>\n<\/div>\n<\/td>\n<\/tr>\n

08 Dec 2023<\/td>\n\n
\n

Notification of the appointment of Company Secretary<\/a><\/p>\n<\/div>\n<\/td>\n<\/tr>\n

07 Dec 2023<\/td>\n\n
\n

Report on the results of the Exercise of EKH-W1 (F53-5)<\/a><\/p>\n<\/div>\n<\/td>\n<\/tr>\n

01 Dec 2023<\/td>\n\n
\n

Rights of shareholders to propose 2024 AGM agenda and nominate director candidates<\/a><\/p>\n<\/div>\n<\/td>\n<\/tr>\n

20 Nov 2023<\/span><\/td>\n\n
\n

Establishment of a joint venture company to operate a psychiatric hospital business (Additional information details) (Revised)<\/a><\/p>\n<\/div>\n<\/td>\n<\/tr>\n

14 Nov 2023<\/td>\n\n
\n

Establishment of a joint venture company to operate a psychiatric hospital business<\/a><\/p>\n<\/div>\n<\/td>\n<\/tr>\n

14 Nov 2023<\/td>\n\n
\n

Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023<\/a><\/p>\n<\/div>\n<\/td>\n<\/tr>\n

14 Nov 2023<\/td>\n\n
\n

Financial Performance Quarter 3 (F45) (Reviewed)<\/a><\/p>\n<\/div>\n<\/td>\n<\/tr>\n

06 Nov 2023<\/td>\n\n
\n

Notification the exercise of EKH-W1<\/a><\/p>\n<\/div>\n<\/td>\n<\/tr>\n

31 Oct 2023<\/td>\n\n
\n

Resolution of the Resignation of the Company Secretary<\/a><\/p>\n<\/div>\n<\/td>\n<\/tr>\n

10 Aug 2023<\/td>\n\n
\n

The signing of a joint venture agreement to establish a specialized hospital and Nursing Home.<\/a><\/p>\n<\/div>\n<\/td>\n<\/tr>\n

10 Aug 2023<\/td>\n\n
\n

Management Discussion and Analysis Quarter 2 Ending 30 Jun 2023<\/a><\/p>\n<\/div>\n<\/td>\n<\/tr>\n

09 Aug 2023<\/td>\nFinancial Performance Quarter 2 (F45)<\/a><\/td>\n<\/tr>\n
31 Jul 2023<\/td>\nReport on the utilization of proceeds from the Capital Increase from Private Placement and from the Exercising of EKH-W1<\/a><\/td>\n<\/tr>\n
09 Jun 2023<\/td>\nNew shares of EKH to be traded on June 12, 2023<\/a><\/td>\n<\/tr>\n
06 Jun 2023<\/td>\nReport on the results of the Exercise of EKH-W1 (F53-5)<\/a><\/td>\n<\/tr>\n
23 May 2023<\/td>\nNew shares of EKH to be traded on May 24, 2023<\/a><\/td>\n<\/tr>\n
19 May 2023<\/td>\nReport on the result of stock dividend allocation (F53-5)<\/a><\/td>\n<\/tr>\n
11 May 2023<\/td>\nManagement Discussion and Analysis Quarter 1 Ending 31 Mar 2023<\/a><\/td>\n<\/tr>\n
11 May 2023<\/td>\nFinancial Performance Quarter 1 (F45)<\/a><\/td>\n<\/tr>\n
10 May 2023<\/td>\nPublication of the minutes of Annual General Shareholders Meeting for 2023 on the Company’s website<\/a><\/td>\n<\/tr>\n
03 May 2023<\/td>\nNotification the exercise of EKH-W1<\/a><\/td>\n<\/tr>\n
25 Apr 2023<\/td>\nShareholders meeting’s resolution<\/a><\/td>\n<\/tr>\n
28 Mar 2023<\/td>\n\n
\n

Publication of the 2023 Annual General Shareholders Meeting invitation on the company website<\/a><\/p>\n<\/div>\n<\/td>\n<\/tr>\n

28 Feb 2023<\/td>\nDividend payment, Right adjustment for warrants exercise and 2023 Annual Ordinary General Meeting of Shareholders (Revised F53-4)<\/a><\/td>\n<\/tr>\n
28-02-2023<\/td>\nRight Adjustment of EKH-W1<\/a><\/td>\n<\/tr>\n
27-02-2023<\/td>\nDividend payment, Right adjustment for warrants exercise and 2023 Annual Ordinary General Meeting of Shareholders (Revised F53-4)<\/a><\/td>\n<\/tr>\n
27-02-2023<\/td>\nFinancial Statement Yearly 2022 (Audited)<\/a><\/td>\n<\/tr>\n
31-01-2023<\/td>\nReport on the utilization of proceeds from the Capital Increase from Private Placement and from the No.1 exercising of EKH-W1<\/a><\/td>\n<\/tr>\n
22-11-2022<\/td>\nNew shares of EKH to be traded on November 23, 2022<\/a><\/td>\n<\/tr>\n
21-11-2022<\/td>\nManagement Discussion and Analysis for the third quarter ending 30 September 2022<\/a><\/td>\n<\/tr>\n
21-11-2022<\/td>\nFinancial Statement Quarter 3.2022<\/a><\/td>\n<\/tr>\n
17-11-2022<\/td>\n Report on the results of the Exercise of EKH-W1 (F53-5)<\/a><\/td>\n<\/tr>\n
11-11-2022<\/td>\nFinancial Performance Quarter 3 (F45)<\/a><\/td>\n<\/tr>\n
11-08-2022<\/td>\nFinancial Performance Quarter 2 (F45) (Reviewed)<\/a><\/td>\n<\/tr>\n
18-07-2022<\/td>\nReport on the results of sale of common shares offered to private placement (F53-5)<\/a><\/td>\n<\/tr>\n
12-07-2022<\/td>\nDetermination of the subscription and payment date for the Company’s newly issued ordinary shares which is allocated to Private Placement<\/a><\/td>\n<\/tr>\n
11-07-2022<\/td>\nNo Right Adjustment of EKH-W1<\/a><\/td>\n<\/tr>\n
29-06-2022<\/td>\nShareholders meeting’s resolution<\/a><\/td>\n<\/tr>\n
01-06-2022<\/td>\nNo Right Adjustment of EKH-W1<\/a><\/td>\n<\/tr>\n
23-05-2022<\/td>\nBoard Resolution on Issuing Newly Ordinary Shares for Private Placement and Extraordinary General Meeting of Shareholders No.1\/2022 (Revised No.3-Additional Agendas)<\/a><\/td>\n<\/tr>\n
23-05-2022<\/td>\nResolution of 2022 Annual General Meeting (Edit the resolution of agenda 11)<\/a><\/td>\n<\/tr>\n
17-05-2022<\/td>\nReport on the result of stock dividend allocation (F53-5)<\/a><\/td>\n<\/tr>\n
12-05-2022<\/td>\nFinancial Performance Quarter 1 (F45) (Reviewed)<\/a><\/td>\n<\/tr>\n
12-05-2022<\/td>\nBoard Resolution on Issuing Newly Ordinary Shares for Private Placement and Extraordinary General Meeting of Shareholders No.1\/2022 (More information) (Revised)<\/a><\/td>\n<\/tr>\n
11-05-2022<\/td>\nPublication of the minutes of Annual General Shareholders Meeting for 2022 on the Company’s website<\/a><\/td>\n<\/tr>\n
06-05-2022<\/td>\nForm to Report on Names of Members and Scope of Work of the Audit Committee (F24-1)<\/a><\/td>\n<\/tr>\n
03-05-2022<\/td>\nRight Adjustment of EKH-W1<\/a><\/td>\n<\/tr>\n
29-04-2022<\/td>\nBoard Resolution on Issuing Newly Ordinary Shares for Private Placement and Extraordinary General Meeting of Shareholders No.1\/2022 (More information)<\/a><\/td>\n<\/tr>\n
27-04-2022<\/td>\nBoard Resolution on Issuing Newly Ordinary Shares for Private Placement and Extraoordinary General Meeting of Shareholders No.1\/2022 (Edit English File)<\/a><\/td>\n<\/tr>\n
27-04-2022<\/td>\nBoard Resolution on Issuing Newly Ordinary Shares for Private Placement and Extroordinary General Meeting of Shareholders No.1\/2022<\/a><\/td>\n<\/tr>\n
27-04-2022<\/td>\nShareholders meeting’s resolution<\/a><\/td>\n<\/tr>\n
19-04-2022<\/td>\nDividend Payment, Right Adjustment for Warrants Exercise and 2022 Annual Ordinary General Meeting of Shareholders (Attached to the Capital Increase Report Form F53-4)<\/a><\/td>\n<\/tr>\n
04-04-2022<\/td>\nPublication of the 2022 Annual General Shareholders Meeting invitation on the company website<\/a><\/td>\n<\/tr>\n
02-03-2022<\/td>\nDividend Payment, Right Adjustment for Warrants Exercise and 2022 Annual Ordinary General Meeting of Shareholders (Add template)<\/a><\/td>\n<\/tr>\n
25-02-2022<\/td>\nDividend Payment, Right Adjustment for Warrants Exercise and 2022 Annual Ordinary General Meeting of Shareholders<\/a><\/td>\n<\/tr>\n
24-02-2022<\/td>\nFinancial Performance Yearly (F45) (Audited)<\/a><\/td>\n<\/tr>\n
07-12-2021<\/td>\nRights of shareholders to propose 2022 AGM agenda and nominate director candidates<\/a><\/td>\n<\/tr>\n
24-11-2021<\/td>\nInformation Memorandum of the Warrants to Purchase the Ordinary Shares of Ekachai Medical Care Public Company Limited No. 1 (EKH-W1)<\/a><\/td>\n<\/tr>\n
19-11-2021<\/td>\nReport on the results of the sale of EKH-W1 offered to existing common shareholders (F53-5) (Edit Template)<\/a><\/td>\n<\/tr>\n
16-11-2021<\/td>\nPublication the minutes of the Extraordinary General Meeting of Shareholders No.1\/2021 on the Company’s website<\/a><\/td>\n<\/tr>\n
15-11-2021<\/td>\nReport on the results of sale of EKH-W1 offered to existing common shareholders (F53-5)<\/a><\/td>\n<\/tr>\n
10-11-2021<\/td>\nFinancial Performance Quarter 3 (F45) (Reviewed)<\/a><\/td>\n<\/tr>\n
29-10-2021<\/td>\nThe information on investment the Acquisition of Shares in The Klinique Medical Clinic Public Company Limited (Revised)<\/a><\/td>\n<\/tr>\n
28-10-2021<\/td>\nThe information on investment the Acquisition of Shares in The Klinique Medical Clinic Public Company Limited<\/a><\/td>\n<\/tr>\n
27-10-2021<\/td>\nShareholders meeting’s resolution<\/a><\/td>\n<\/tr>\n
14-10-2021<\/td>\nPublication of the invitation letter for the Extraordinary General Meeting of Shareholders No. 1\/2021 on the Company’s website<\/a><\/td>\n<\/tr>\n
20-09-2021<\/td>\nIssuance of Warrants to Purchase Ordinary Shares and the Date of Extraordinary General Meeting No. 1\/2021 (Revised)<\/a><\/td>\n<\/tr>\n
17-09-2021<\/td>\nIssuance of Warrants to Purchase Ordinary Shares and the Date of Extraordinary General Meeting No. 1\/2021 (Revised)<\/a><\/td>\n<\/tr>\n
17-09-2021<\/td>\nIssuance of Warrants to Purchase Ordinary Shares and the Date of Extraordinary General Meeting No. 1\/2021<\/a><\/td>\n<\/tr>\n
23-08-2021<\/td>\nReport Form for the Resale of Shares on the Stock Exchange dated 20 August 2021<\/a><\/td>\n<\/tr>\n
20-08-2021<\/td>\nReport Form for the Resale of Shares on the Stock Exchange dated 19 August 2021<\/a><\/td>\n<\/tr>\n
10-08-2021<\/td>\nInterim Dividend Payment<\/a><\/td>\n<\/tr>\n
10-08-2021<\/td>\nFinancial Performance Quarter 2 (F45) (Reviewed)<\/a><\/td>\n<\/tr>\n
02-08-2021<\/td>\nReport on the Use of Proceeds from the Capital Increase as of June 30, 2021<\/a><\/td>\n<\/tr>\n
09-07-2021<\/td>\nReport Form for the Resale of Shares on the Stock Exchange dated 9 July 2021<\/a><\/td>\n<\/tr>\n
08-07-2021<\/td>\nReport Form for the Resale of Shares on the Stock Exchange dated 8 July 2021<\/a><\/td>\n<\/tr>\n
08-07-2021<\/td>\nReport Form for the Resale of Shares on the Stock Exchange dated 7 July 2021<\/a><\/td>\n<\/tr>\n
11-06-2021<\/td>\nReport Form for the Resale of Shares on the Stock Exchange dated 10 June 2021<\/a><\/td>\n<\/tr>\n
02-06-2021<\/td>\nReport Form for the Resale of Shares on the Stock Exchange dated 1 June 2021<\/a><\/td>\n<\/tr>\n
31-05-2021<\/td>\nPublication of the minutes of Annual General Shareholders Meeting for 2021 on the Company’s website<\/a><\/td>\n<\/tr>\n
13-05-2021<\/td>\nFinancial Performance Quarter 1 (F45) (Reviewed)<\/a><\/td>\n<\/tr>\n
28-04-2021<\/td>\nForm to Report on Names of Members and Scope of Work of the Audit Commitee (F24-1)<\/a><\/td>\n<\/tr>\n
27-04-2021<\/td>\nShareholders meeting’s resolution<\/a><\/td>\n<\/tr>\n
12-04-2021<\/td>\nReport Form for the Resale of Shares on the Stock Exchange dated 12 April 2021<\/a><\/td>\n<\/tr>\n
09-04-2021<\/td>\nReport Form for the Resale of Shares on the Stock Exchange dated 9 April 2021<\/a><\/td>\n<\/tr>\n
02-04-2021<\/td>\nPublication of the 2021 Annual General Shareholders Meeting invitation on the company website<\/a><\/td>\n<\/tr>\n
31-03-2021<\/td>\nReport Form for the Resale of Shares on the Stock Exchange (Revise Template)<\/a><\/td>\n<\/tr>\n
30-03-2021<\/td>\nReport Form for the Resale of Shares on the Stock Exchange<\/a><\/td>\n<\/tr>\n
25-02-2021<\/td>\nNotification of the period for resale of the Company’s repurchased shares under the share repurchase scheme (Treasury Stock) for financial management purposes<\/a><\/td>\n<\/tr>\n
25-02-2021<\/td>\nFinancial Performance Yearly (F45) (Audited)(Revise)<\/a><\/td>\n<\/tr>\n
25-02-2021<\/td>\nDividend Payment and 2020 Annual Ordinary General Meeting of Shareholders<\/a><\/td>\n<\/tr>\n
25-02-2021<\/td>\nFinancial Performance Yearly (F45) (Audited)<\/a><\/td>\n<\/tr>\n
29-01-2021<\/td>\nReport on the Use of Proceeds from the Capital Increase as of December 31, 2020<\/a><\/td>\n<\/tr>\n
15-Dec-2020<\/td>\nChange the business of a subsidiary<\/a><\/td>\n<\/tr>\n
01-Dec-2020<\/td>\nRights of shareholders to propose 2021 AGM agenda and nominate director candidates<\/a><\/td>\n<\/tr>\n
11-Nov-2020<\/td>\nFinancial Performance Quarter 3 (F45) (Reviewed)<\/a><\/td>\n<\/tr>\n
05-Oct-2020<\/td>\nNotification on the End of the Share Repurchase Project for Financial Management Purposes<\/a><\/td>\n<\/tr>\n
05-Oct-2020<\/td>\nShares Repurchased Report dated 2 October 2020<\/a><\/td>\n<\/tr>\n
02-Oct-2020<\/td>\nShares Repurchased Report dated 1 October 2020<\/a><\/td>\n<\/tr>\n
30-Sep-2020<\/td>\nShares Repurchased Report dated 30 September 2020<\/a><\/td>\n<\/tr>\n
29-Sep-2020<\/td>\nShares Repurchased Report dated 29 September 2020<\/a><\/td>\n<\/tr>\n
28-Sep-2020<\/td>\nShares Repurchased Report dated 28 September 2020<\/a><\/td>\n<\/tr>\n
28-Sep-2020<\/td>\nShares Repurchased Report dated 25 September 2020<\/a><\/td>\n<\/tr>\n
24-Sep-2020<\/td>\nShares Repurchased Report dated 24 September 2020<\/a><\/td>\n<\/tr>\n
23-Sep-2020<\/td>\nShares Repurchased Report dated 23 September 2020<\/a><\/td>\n<\/tr>\n
23-Sep-2020<\/td>\nShares Repurchased Report dated 22 September 2020<\/a><\/td>\n<\/tr>\n
21-Sep-2020<\/td>\nShares Repurchased Report dated 21 September 2020<\/a><\/td>\n<\/tr>\n
21-Sep-2020<\/td>\nShares Repurchased Report dated 18 September 2020<\/a><\/td>\n<\/tr>\n
18-Sep-2020<\/td>\nShares Repurchased Report dated 17 September 2020<\/a><\/td>\n<\/tr>\n
15-Sep-2020<\/td>\nShares Repurchased Report dated 14 September 2020<\/a><\/td>\n<\/tr>\n
10-Sep-2020<\/td>\nShares Repurchased Report dated 10 September 2020<\/a><\/td>\n<\/tr>\n
14-Aug-2020<\/td>\nRatification of the connected transactions<\/a><\/td>\n<\/tr>\n
11-Aug-2020<\/td>\nFinancial Performance Quarter 2 (F45) (Reviewed)<\/a><\/td>\n<\/tr>\n
29-Jul-2020<\/td>\nReport on the Use of Proceeds from the Capital Increase as of June 30, 2020<\/a><\/td>\n<\/tr>\n
09-Jul-2020<\/td>\nResolution of 2020 Annual General Meeting<\/a><\/td>\n<\/tr>\n
15-Jun-2020<\/td>\nPublication of the 2020 Annual General Shareholders Meeting invitation on the company website<\/a><\/td>\n<\/tr>\n
14-May-2020<\/td>\nNotification of resolutions setting forth the Annual Ordinary General Meeting of Shareholders in 2020<\/a><\/td>\n<\/tr>\n
14-May-2020<\/td>\nReviewed financial performance Quarter 1 (F45)<\/a><\/td>\n<\/tr>\n
13-May-2020<\/td>\nReviewed financial performance Quarter 1 (F45)<\/a><\/td>\n<\/tr>\n
13-May-2020<\/td>\nThe appointment of the auditors<\/a><\/td>\n<\/tr>\n
10-Apr-2020<\/td>\nInterim Dividend Payment<\/a><\/td>\n<\/tr>\n
10-Apr-2020<\/td>\nNotification of the postponement of the Annual General Meeting of Shareholders for the year 2020 and the Approval of Interim Dividend Payment<\/a><\/td>\n<\/tr>\n
30-Mar-2020<\/td>\nPublication of the 2020 Annual General Shareholders Meeting invitation on the company website<\/a><\/td>\n<\/tr>\n
19-Mar-2020<\/td>\nResolution of the Board of Directors’ Meeting on the Share Repurchase Program for Financial Management<\/a><\/td>\n<\/tr>\n
27-Feb-2020<\/td>\nDividend Payment and 2020 Annual Ordinary General Meeting of Shareholders<\/a><\/td>\n<\/tr>\n
27-Feb-2020<\/td>\nAudited Yearly financial performance (F45)<\/a><\/td>\n<\/tr>\n
31-Jan-2020<\/td>\nReport on the Use of Proceeds from the Capital Increase as of December 31, 2019<\/a><\/td>\n<\/tr>\n
02-Dec-19<\/td>\nRights of shareholders to propose 2020 AGM agenda and nominate director candidates<\/a><\/td>\n<\/tr>\n
29-Nov-2019<\/td>\nOpening of Children’s Center<\/a><\/td>\n<\/tr>\n
11-Nov-2019<\/td>\nReviewed financial performance Quarter 3 (F45)<\/a><\/td>\n<\/tr>\n
14-Aug-2019<\/td>\nEstablishment of New Subsidiary<\/a><\/td>\n<\/tr>\n
13-Aug-2019<\/td>\nReviewed Quarter 2 and Consolidated F\/S (F45-3)<\/a><\/td>\n<\/tr>\n
31-Jul-2019<\/td>\nReport on the Use of Proceeds from the Capital Increase as of June 30, 2019<\/a><\/td>\n<\/tr>\n
15-May-2019<\/td>\nClarification of Big Lot transaction<\/a><\/td>\n<\/tr>\n
15-May-2019<\/td>\nAppointment of new director and notification of changes in authorized signatories<\/a><\/td>\n<\/tr>\n
14-May-2019<\/td>\nForm to Report on Names of Members and Scope of Work of the Audit Committee (F24-1)<\/a><\/td>\n<\/tr>\n
13-May-2019<\/td>\nReviewed Quarter 1 and Consolidated F\/S (F45-3)<\/a><\/td>\n<\/tr>\n
25-Apr-2019<\/td>\nShareholders meeting’s resolution<\/a><\/td>\n<\/tr>\n
26-Mar-2019<\/td>\nPublication of the 2019 Annual General Shareholders Meeting invitation on the company website<\/a><\/td>\n<\/tr>\n
21-Mar-2019<\/td>\nNotification of the Resignation of Director<\/a><\/td>\n<\/tr>\n
26-Feb-2019<\/td>\nDividend Payment and 2019 Annual Ordinary General Meeting of Shareholders<\/a><\/td>\n<\/tr>\n
25-Feb-2019<\/td>\nDividend Payment and 2019 Annual Ordinary General Meeting of Shareholders<\/a><\/td>\n<\/tr>\n
25-Feb-2019<\/td>\nAudited Yearly and Consolidated F\/S (F45-3)<\/a><\/td>\n<\/tr>\n
30-Jan-2019<\/td>\nReport on the Use of Proceeds fromthe Capital Increase asof December 31, 2018<\/a><\/td>\n<\/tr>\n
21-Dec-2018<\/td>\nRights of shareholders to propose 2019 AGM agenda and nominate director candidates<\/a><\/td>\n<\/tr>\n
13-Nov-2018<\/td>\nThe increase of shareholding proportion by buying of 23% newly issued common shares of Ekachai International Co., Ltd., which is Ekachai Medical Care PCL. subsidiary.<\/a><\/td>\n<\/tr>\n
12-Nov-2018<\/td>\nReviewed Quarter 3 and Consolidated F\/S (F45-3)<\/a><\/td>\n<\/tr>\n
09-Aug-2018<\/td>\nReviewed Quarter 2 and Consolidated F\/S (F45-3)<\/a><\/td>\n<\/tr>\n
31-Jul-2018<\/td>\nReport on the Use of Proceeds from the Capital Increase as of June 30, 2018<\/a><\/td>\n<\/tr>\n
14-May-2018<\/td>\nReviewed Quarter 1 and Consolidated F\/S (F45-3)<\/a><\/td>\n<\/tr>\n
23-Apr-2018<\/td>\nShareholders meeting’s resolution<\/a><\/td>\n<\/tr>\n
30-Mar-2018<\/td>\nPublication of the 2018 Annual General Shareholders Meeting invitation on the company website<\/a><\/td>\n<\/tr>\n
27-Feb-2018<\/td>\nInformation Memorandum on Acquiring of Common Shares in Ekachai International Co., Ltd. (Revised)<\/a><\/td>\n<\/tr>\n
27-Feb-2018<\/td>\nInformation Memorandum on Acquiring of Common Shares in Ekachai International Co., Ltd.<\/a><\/td>\n<\/tr>\n
26-Feb-2018<\/td>\nDividend Payment and 2018 Annual Ordinary General Meeting of Shareholders<\/a><\/td>\n<\/tr>\n
26-Feb-2018<\/td>\nAudited Yearly and Consolidated F\/S (F45-3)<\/a><\/td>\n<\/tr>\n
30-Jan-2018<\/td>\nReport on the Use of Proceeds from the Capital Increase as of December 31, 2017<\/a><\/td>\n<\/tr>\n
08-Jan-2018<\/td>\nOpening of IVF center of Ekachai International Company Limited<\/a><\/td>\n<\/tr>\n
13-Dec-2017<\/td>\nRights of shareholders to propose 2018 AGM agenda and nominate director candidates<\/a><\/td>\n<\/tr>\n
13-Nov-2017<\/td>\nReviewed Quarter 3 and Consolidated F\/S (F45-3)<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

DATE Announcements 02 Mar 2026 Related Party Transaction of a Subsidiary (Acquisition of Land in Replacement of Lease) 27 Feb 2026 Dividend payment and 2026 Annual General Meeting of Shareholders 27 Feb 2026 Financial Performance Yearly (F45) (Audited) 27 Feb 2026 Management Discussion and Analysis Yearly Ending 31 Dec 2025 29 Jan 2026 Report on […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":1536,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-1958","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.ekachaihospital.com\/en\/wp-json\/wp\/v2\/pages\/1958","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ekachaihospital.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ekachaihospital.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ekachaihospital.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ekachaihospital.com\/en\/wp-json\/wp\/v2\/comments?post=1958"}],"version-history":[{"count":42,"href":"https:\/\/www.ekachaihospital.com\/en\/wp-json\/wp\/v2\/pages\/1958\/revisions"}],"predecessor-version":[{"id":2742,"href":"https:\/\/www.ekachaihospital.com\/en\/wp-json\/wp\/v2\/pages\/1958\/revisions\/2742"}],"up":[{"embeddable":true,"href":"https:\/\/www.ekachaihospital.com\/en\/wp-json\/wp\/v2\/pages\/1536"}],"wp:attachment":[{"href":"https:\/\/www.ekachaihospital.com\/en\/wp-json\/wp\/v2\/media?parent=1958"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}